Theophylline-induced recovery in a hemidiaphragm paralyzed by hemisection in rats: Contribution of adenosine receptors

Neuropharmacology

Volumn 37, Issue 1, 1998, Pages 113-121

  Nantwi, Kwaku D ^a   Goshgarian, Harry G ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cervical spinal cord injury; Enprofylline; Functional recovery; Latent respiratory pathways; Theophylline

Indexed keywords

ADENOSINE RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ENPROFYLLINE; METHYLXANTHINE; PHENYLISOPROPYLADENOSINE; THEOPHYLLINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CERVICAL SPINAL CORD INJURY; CONTROLLED STUDY; DIAPHRAGM PARALYSIS; DOSE RESPONSE; DRUG MECHANISM; DRUG MIXTURE; FEMALE; NONHUMAN; PHRENIC NERVE; PRIORITY JOURNAL; RAT; SPINAL CORD HEMISECTION;

ANIMALS; BRONCHODILATOR AGENTS; DIAPHRAGM; ELECTROPHYSIOLOGY; FEMALE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PURINERGIC P1; SPINAL CORD; THEOPHYLLINE; XANTHINES;

EID: 0031809435     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(97)00190-1     Document Type: Article

References (28)

1. Arnold J.D., Courtenay-Evans R.J., Whitfieldm R., O'Reilley J.F., Petries G.R., Higgins A.J., Swift C.G. Comparative assessment of enprofylline and theophylline for obstructive airways disease in the elderly. Resp. Med. 84:1990;211-215.
2. Boe J., Eriksson G., Ljungholm K. Efficacy of enprofylline, a new bronchodilating xanthine in acute asthma. Ann. Allergy. 59:1987;155-158.
3. Borga O., Andersson K.K., Edholm L.E., Fagerstromm P.O., Lunell E., Persson C.G. Enprofylline kinetics in healthy subjects after single doses. Clin. Pharmacol. Ther. 34(6):1983;799-804.
4. Chapman K.R., Ljungholm K., Kallen A. Long-term xanthine therapy of asthma enprofylline and theophylline compared. Chest. 106(5):1994;1407-1413.
5. Daly J.W., Padgett W., Shamim M.T., Butts-Lamb P., Waters J. 1,3-Dialkyl-8-(p-sulfophenyl) xanthines: potent water-soluble antagonists for A1- and A2- adenosine receptors. J. Med. Chem. 28:1985;487-492.
6. Eldridge F.L., Milhorn D.E., Kiley J.P Antagonism by theophylline of respiratory inhibition induced by adenosine. J. Appl. Physiol. 59:1985;1428-1433.
7. Fredholm B.B., Persson C.G.A. Xanthine derivatives as adenosine receptor antagonists. Eur. J. Pharmacol. 81:1982;673-676.
8. Goshgarian H.G. Developmental plasticity in the respiratory pathway of the adult rat. Exp. Neurol. 66:1979;547-555.
9. Goshgarian H.G., Guth L. Demonstration of functionally ineffective synapses in the guinea pig spinal cord. Exp. Neurol. 57:1977;613-621.
10. Goshgarian H.G., Moran M.F., Prcevski P Effect of cervical spinal cord hemisection and diaphragm paralysis on arterial blood gases, pH and respiratory rate in the adult rat. Exp. Neurol. 93:1986;440-445.
11. Haghoo S., Hasegawa T., Nadia M., Wang L., Ishigaki T., Miyamoto K., Nabeshima T. Brain distribution characteristics of xanthine derivatives and relation to their locomotor activity in mice. J. Pharm. Pharmacol. 47(5):1995;412-419.
12. Laursen L.C., Borga O., Krohn L., Weeke B. Distribution of enprofylline and theophylline between plasma and cerebrospinal fluid. Ther. Drug Monit. 11:1989;162-164.
13. Laursen L.C., Johannesson N., Sondergaard I., Weeke B. Comparison of oral enprofylline and theophylline in asthmatic patients. Eur. J. Clin. Pharmacol. 26:1984;707-709.
14. Laursen L.C., Johannesson N., Fagerstrom P.O., Weeke B. Intravenous administration of enprofylline to asthmatic patients. Eur. J. Clin. Pharmacol. 24:1983;323-327.
15. Lewis L.J., Brookhart J.M. Significance of the crossed phrenic phenomenon. Am. J. Physiol. 166:1951;241-254.
16. Liou W.W., Goshgarian H.G. Quantitative assessment of the effect of chronic phrenicotomy on the induction of the crossed phrenic phenomenon. Exp. Neurol. 127:1994;145-153.
17. Liou W.W., Goshgarian H.G. The superimposed effects of chronic cervical spinal cord hemisection on glial cytoarchitecture in the rat phrenic nucleus. J. Spinal Cord Med. 19(2):1996;58-70.
18. Lunell E., Svedmyr N., Andersson K.E., Persson C.G.A. Effects of Enprofylline, a xanthine lacking adenosine antagonism, in patients with reversible obstructive lung disease. Eur. J. Clin. Pharmacol. 22:1982;395-402.
19. Moreno D.E., Yu X.-J., Goshgarian H.G Identification of the axon pathways which mediate functional recovery of a paralyzed hemidiaphragm following spinal cord hemisection in the adult rat. Exp. Neurol. 116:1992;219-228.
20. Moss I.R., Denavit-Saubie M., Eldridge F.L., Gillis R.A., Herenham M., Lahiri S. Neuromodulators and Transmitters in Respiratory Control. Fed. Proc. 45:1986;2133-2147.
21. Nantwi K.D., El-Bohy A., Goshgarian H.G. Actions of systemic theophylline on hemidiaphragmatic recovery in rats following cervical spinal cord hemisection. Exp. Neurol. 140:1996;53-59.
22. O'Hara T.E. Jr., Goshgarian H.G. Quantitative assessment of phrenic nerve functional recovery mediated by the crossed phrenic reflex at various time intervals after spinal cord injury. Exp. Neurol. 111:1991;244-250.
23. Persson C.G.A., Erjefalt I. Seizure activity in animals given enprofylline and theophylline, two xanthines with partly different mechanisms of action. Arch. Int. Pharmacodyn. 258:1982;267-282.
24. Persson C.G.A., Erjefalt I., Karlsson J.A. Adenosine antagonism, a less desirable characteristic of Xanthine asthma drugs? Acta Pharmacol. Toxicol. 49:1981;317.
25. Persson C.G.A., Kjellin G. Enprofylline, a principally new antiasthmatic xanthine. Acta Pharmacol. Toxicol. 49:1981;313-316.
26. Persson C.G.A., Anderson K.E., Kjellin G. Effects of enprofylline and theophylline may show role of adenosine. Life Sci. 38:1986;1057-1072.
27. Rall, T. W., 1990. Drugs used in treatment of asthma. The methylxanthines, cromolyn sodium, and other agents. In: Gilman, A.G., Rall, T.W., Nies, A.S., Taylor, P., (Eds.). The Pharmacological Basis of Therapeutics. Pergamon Press, pp. 618-637.
28. Vilsvik J.S., Persson C.G.A., Amundsen T. et al. Comparison between theophylline and an adenosine nonblocking xanthine in acute asthma. Eur. Resp. J. 3:1990;27-32.